BOT 2.82% 34.5¢ botanix pharmaceuticals ltd

Ann: Ethics Approval for BTX 1308 Psoriasis Patient Study Secured, page-37

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,889 Posts.
    lightbulb Created with Sketch. 768
    Have to agree with you Bernsta, I too believe BOT have a great suite of potential products,,, although I wish I could agree with a rush on the SP but thats the 2nd tier obstacle of having such a large discounted CR,, the rinse and churn of the Insto... I hope I'm wrong and we run straight through the 139,000.000 shares they have,, but check BOT volume and the last rinse,, even with great news these guys will take a loooong time to get rid of.. just the way the market works,, currently a 100% increase would see us back to pre CR levels... Again I hope you are right ,,,, I just go by the past history..... you need a decent graph to tell the story of "get on board" at present thats flatlined and the market know BOT have a lot of churn from the Insto to wade through....so no urgency means no demand,,, 
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
34.5¢
Change
-0.010(2.82%)
Mkt cap ! $707.4M
Open High Low Value Volume
36.0¢ 36.0¢ 34.5¢ $424.9K 1.207M

Buyers (Bids)

No. Vol. Price($)
11 254414 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 53441 6
View Market Depth
Last trade - 12.39pm 27/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.